Application 761429
- Type
- BLA
- Sponsor
- BRISTOL-MYERS SQUIBB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OPDIVO QVANTIG | NIVOLUMAB;HYALURONIDASE-NVHY | INJECTABLE;INJECTION | 600MG;10000 UNITS PER 5ML(120MG/2000UNITS PER ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPDIVO QVANTIG | NIVOLUMAB AND HYALURONIDASE-NVHY | E.R. Squibb & Sons, L.L.C. | 7f8c38fa-42f4-4387-9e8c-7a1c66855d8b | 2026-05-12 | Warnings, Adverse reactions | OPDIVO QVANTIG |